Roche head office, Basel
Basel, Switzerland (GenevaLunch) – Pharmaceutical multinational Roche says its turnover fell by 22 percent in 2009 compared to 2008 due to charges linked to its purchase of US company Genentech. Operating profits rose by 14 percent before the exceptional charges, however, and the company had record sales, up 10 percent to CHF49.1 billion.
Posted by Ellen Wallace on 3 February 2010 at 11:14 | permalink
This work by genevalunch.com is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported.
News story, GenevaLunch, 3 February 2010.
Filed under: Business
Tags: 2009 results, Basel, profits, Roche, sales, turnover
We are happy to have your comments, which are approved before they appear: please remember to be courteous and brief. We accept only comments directly related to an article. We do not accept comment spam - messages sent to more than one site. We do not publish comments if the e-mail address is not legitimate. Thank you!